Autres langues ProKidney Corp.

Actions

PROK

KYG7S53R1049

Cours en clôture Nasdaq Autres places de cotation 00:00:00 03/05/2024			Varia. 5j.	Varia. 1 janv.
2,2 ^USD	+2,33%		+3,77%	+23,60%

25/03	ProKidney Corp. annonce des nominations clés au sein de son équipe de direction pour renforcer les opérations cliniques et techniques	CI
22/03	ProKidney affiche une perte plus importante pour 2023	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations	25/03
ProKidney Corp. Announces Key Leadership Appointments Strengthening Clinical and Technical Operations	25/03
ProKidney Posts Wider 2023 Loss	22/03
ProKidney Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	22/03
ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights	22/03
ProKidney to Participate in Jefferies Biotech on the Bay Summit	29/02
Chronic Kidney Disease Pipeline, FDA Approvals, Clinical Trials Developments, Companies 2023 \| Boehringer Ingelheim, Eli Lilly and Company, Reata Pharmaceuticals, Novo Nordisk, Prokidney, and others.	05/12
ProKidney Corp. Announces Termination of Deepak Jain as Chief Operating Officer	30/11
ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer	30/11
Prokidney Appoints Nikhil Pereira-Kamath as Chief Business Officer	30/11
ProKidney Files $500 Million Mixed Shelf	22/11
Prokidney Insider Sold Shares Worth $9,498,584, According to a Recent SEC Filing	21/11
ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference	21/11
Sector Update: Health Care Stocks Advance in Late Afternoon Trading	20/11
Sector Update: Health Care	20/11
Top MIdday Gainers	20/11
ProKidney Corp. announces an Equity Buyback for 7,256,367 shares, for $9.5 million.	20/11
ProKidney Corp. authorizes a Buyback Plan.	19/11
ProKidney Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
ProKidney Reports Third Quarter Financial Results	14/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues ProKidney Corp.

Actions

PROK

KYG7S53R1049

Autres langues

Filtres